Bank Of New York Mellon Corp Anixa Biosciences Inc Transaction History

Bank Of New York Mellon Corp

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$3.86 - $5.0 $376,805 - $488,090	97,618 New	97,618 $420 Million
Q4 2022 Feb 14, 2023	BUY	$3.78 - $5.81 $368,996 - $567,160	97,618 New	97,618 $414,000
Q2 2022 Aug 15, 2022	SELL	$2.55 - $4.1 $2,029 - $3,263	-796 Reduced 0.81%	97,856 $299,000
Q3 2021 Nov 12, 2021	BUY	$3.57 - $5.6 $197,599 - $309,960	55,350 Added 127.82%	98,652 $471,000
Q2 2021 Aug 11, 2021	SELL	$3.46 - $4.92 $26,434 - $37,588	-7,640 Reduced 15.0%	43,302 $168,000
Q1 2021 May 13, 2021	SELL	$3.27 - $7.14 $3,358 - $7,332	-1,027 Reduced 1.98%	50,942 $238,000
Q4 2020 Feb 09, 2021	BUY	$1.94 - $3.19 $24,420 - $40,155	12,588 Added 31.96%	51,969 $159,000
Q1 2020 May 06, 2020	SELL	$1.35 - $4.06 $2,134 - $6,418	-1,581 Reduced 3.86%	39,381 $62,000
Q4 2019 Feb 14, 2020	BUY	$2.78 - $4.03 $3,347 - $4,852	1,204 Added 3.03%	40,962 $134,000
Q2 2019 Aug 12, 2019	SELL	$3.47 - $4.75 $170 - $232	-49 Reduced 0.12%	39,758 $144,000
Q1 2019 May 14, 2019	SELL	$3.85 - $5.53 $12,212 - $17,541	-3,172 Reduced 7.38%	39,807 $180,000
Q4 2018 Feb 11, 2019	BUY	$3.37 - $6.59 $144,839 - $283,231	42,979 New	42,979 $169,000

5.56M

21K

6.7K

Ticker ANIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,661,700
Market Cap $76M
Description
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.